MedPath

Exercise Training in Patients With Chagasic Heart Disease Without Ventricular Dysfunction

Not Applicable
Conditions
Chagas Disease
Interventions
Other: Exercise
Registration Number
NCT02295215
Lead Sponsor
University of Sao Paulo General Hospital
Brief Summary

The prevalence of Chagas' disease continues high even in the developed countries. Chagasic Cardiomyopathy with preserved ventricular function is an understudied form of Chagas disease. Since a majority of patients with these changes progress to dilated form with ventricular dysfunction with all its serious consequences, it is interesting to better understand the pathophysiology of the disease at the stage where there electrocardiographic changes and preserved ventricular function. And besides, search strategies to slow the progress, or even prevent the chronic phase of the disease. For this reason the investigators will evaluate the effects of exercise training in patients with Chagas cardiomyopathy without ventricular dysfunction.

Detailed Description

Chagasic Cardiomyopathy with preserved ventricular function is an understudied form of Chagas disease. Since a majority of patients with these changes progress to dilated form with ventricular dysfunction with all its serious consequences, it is interesting to better understand the pathophysiology of the disease at the stage where there electrocardiographic changes and preserved ventricular function. And besides, search strategies to slow the progress, or even prevent the chronic phase of the disease. For this reason the investigators will evaluate the effects of exercise training in patients with Chagas cardiomyopathy without ventricular dysfunction.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
24
Inclusion Criteria
  • Chagas' disease patients, diagnosed with at least two positive serological reactions to Chagas' disease,
  • Ejection fraction ≥55%
Exclusion Criteria
  • Participation in a regular exercise program in the last 3 months preceding the survey
  • Use of oral anticoagulant
  • Use of a pacemaker or implantable cardioverter
  • Hemodynamic instability
  • Myocardial revascularization infarction or unstable angina in the last 3 months of the start of the protocol
  • Diabetes mellitus
  • Hypertension
  • Pulmonary Disease
  • Valvular lesions
  • Atrial Fibrillation
  • Angina of effort

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Trained GroupExerciseThe patients will do exercise training for sixteen weeks.
Primary Outcome Measures
NameTimeMethod
Sympathetic nerve activityAutonomic control4 months

Exercise training will improve baroreflex sensitivity and reduce sympathetic nerve activity.

Secondary Outcome Measures
NameTimeMethod
Skeletal muscle strength4 months

Exercise training will increase skeletal muscle strength

Peak oxygen consumption4 months

Exercise training will improve peak oxygen consumption

Trial Locations

Locations (1)

Heart Institute - HC-FMUSP

🇧🇷

Sao Paulo, SP, Brazil

© Copyright 2025. All Rights Reserved by MedPath